The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
SOCIETAL VIEWS ON NICE, CANCER DRUGS FUND AND VALUE‐BASED PRICING CRITERIA FOR PRIORITISING MEDICINES: A CROSS‐SECTIONAL SURVEY OF 4118 ADULTS IN GREAT BRITAIN
Abstract
The criteria used by the National Institute for Health and Clinical Excellence (NICE) for accepting higher incremental cost‐effectiveness ratios for some medicines over others, and the recent introduction of the Cancer Drugs Fund (CDF) in England, are assumed to reflect societal preferences for National Health Service resource allocation. Robust empirical evidence to this effect is lacking. To explore societal preferences for these and other criteria, including those proposed for rewarding new medicines under the future value‐based pricing (VBP) system, we conducted a choice‐based experiment in 4118 UK adults via web‐based surveys. Preferences were determined by asking respondents to allocate fixed funds between different patient and disease types reflecting nine specific prioritisation criteria. Respondents supported the criteria proposed under the VBP system (for severe diseases, address unmet needs, are innovative—provided they offered substantial health benefits, and have wider societal benefits) but did not support the end‐of‐life premium or the prioritisation of children or disadvantaged populations as specified by NICE, nor the special funding status for treatments of rare diseases, nor the CDF. Policies introduced on the basis of perceived—and not actual—societal values may lead to inappropriate resource allocation decisions with the potential for significant population health and economic consequences. Copyright © 2012 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Response Rates and Nonresponse Errors in Surveys
Johnson, T. P. (2012) · JAMA · doi:10.1001/jama.2012.3532 · Cited by 701
Pharmacoeconomics: NICE's approach to decision-making
Rawlins, M., Barnett, D., & Stevens, A. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03589.x · Cited by 152
Cited by
Parkhurst, J. (2016) · London School of Economics and Political Science Research Online (London School of Economics and Political Science) · doi:10.4324/9781315675008 · Cited by 756
Metadata
- Authors
- Linley, W. G., & Hughes, D. A.
- Venue
- Health Economics
- Publisher
- Wiley
- Published
- 2012-09-07
- Volume
- 22
- Issue
- 8
- Pages
- 948-964
- ISSN
- 1057-9230 (ISSN-L)
- 1099-1050
- OpenAlex
- W1959331022
- Cited by
- 208
- References
- 2
- FWCI
- 38.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: SOCIETAL VIEWS ON NICE, CANCER DRUGS FUND AND VALUE‐BASED PRICING CRITERIA FOR PRIORITISING MEDICINES: A CROSS‐SECTIONAL SURVEY OF 4118 ADULTS IN GREAT BRITAIN. https://app.cochat.ai/papers/10.1002/hec.2872
- The paper
- Linley, W. G., & Hughes, D. A. (2013). SOCIETAL VIEWS ON NICE, CANCER DRUGS FUND AND VALUE‐BASED PRICING CRITERIA FOR PRIORITISING MEDICINES: A CROSS‐SECTIONAL SURVEY OF 4118 ADULTS IN GREAT BRITAIN. Health Economics. https://doi.org/10.1002/hec.2872
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.